CVS Health Valuation

CVS -- USA Stock  

USD 57.38  0.88  1.56%

CVS Health shows prevailing Real Value of $65.7734 per share. The current price of the firm is $57.38. At this time the firm appears to be undervalued. This module approximates value of CVS Health from analyzing the firm fundamentals such as Return On Equity of (0.34)% and Profit Margin of (0.08)% as well as examining its technical indicators and Probability Of Bankruptcy. In general, we favor to go long with undervalued instruments and to trade away overvalued instruments since at some point future time assets prices and their ongoing real values will blend.
Undervalued
July 19, 2019
57.38
Market Value
65.77
Real Value
69.85
Upside
CVS Health is very steady asset. Calculation of real value of CVS Health is based on 2 months time horizon. Increasing CVS Health time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Investments

Valuation Drivers Correlation

Click cells to compare fundamentals   View All Correlations
CVS Health Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    

CVS Health Market Cap

CVS Health Corporation is rated fifth in market capitalization category among related companies. Market capitalization of Health Care Plans industry is currently estimated at about 588.45 Billion. CVS Health retains roughly 74.54 Billion in market capitalization claiming about 13% of equities under Health Care Plans industry.
Capitalization  Workforce  Total debt  Valuation  Revenue
Horizon     30 Days    Login   to change
CVS Health Corporation is rated fourth in five year return category among related companies. It is rated below average in price to sales category among related companies fabricating about  0.17  of Price to Sales per Five Year Return. The ratio of Five Year Return to Price to Sales for CVS Health Corporation is roughly  5.97 

Valuation Basics

CVS Health Enterprise Value Fundamentals

Quick Ratio0.55
Earnings Quarterly Growth42.40%
Revenue Growth34.40%
Enterprise Value To Ebitda11.91
Earnings Growth11.20%
Enterprise Value To Revenue0.77
Check also Trending Equities. Please also try Money Flow Index module to determine momentum by analyzing money flow index and other technical indicators.
Search macroaxis.com